Stories
Stories
In the UK, She Leads the Search for a COVID Vaccine
Kate Bingham (MBA 1991)
Kate Bingham (MBA 1991)
When she was asked to chair the UK’s Vaccine Taskforce back in May, Kate Bingham (MBA 1991) paused. Despite nearly three decades of experience as a life sciences investor with SV Health Investors, the enormity of leading her country’s effort to put a stop to the spread of COVID-19 was daunting. “When I told my daughter I wasn’t sure I could do this, she looked at me and said, ‘Mum! If I’d said that you’d have given me all this lip about ‘don’t be under-confident, you’re just putting yourself down!’ So I was told off by my 22-year-old,” Bingham told the Daily Mail.
In fact, Bingham’s role—working with pharmaceutical firms, planning manufacturing facilities, and making investment decisions—ties in directly with her career experience. “As a venture capitalist, I have to write a personal check into every single thing I invest my investors’ money in,” she explains. “So they want us personally on the hook with skin in the game for everything we do. That sort of approach is actually what you need in this case. It’s government money, not my money, but the mentality is the same.”
Bingham, who grew up in London and studied biochemistry at Oxford University, is also making a plan for when a vaccine does become available. While a small portion of the UK population is staunchly “anti-vax” her primary concern is those who are fearful of how quickly the vaccine is being developed. “The safety of the clinical trials is not being compromised,” she said. “Vaccine hesitancy is something we need to address, especially in ethnic minority communities who tend not to sign up for vaccine trials. So that’s been a big push in what we’ve been doing with the vaccine registry.”
Post a Comment
Related Stories
-
- 01 Dec 2011
- Alumni Stories
Research With Impact: Changing Global Health Practices
-
- 16 Sep 2016
- Making A Difference
Gaining Ground on ALS
Re: Rob Blum (MBA 1991) -
- 18 Feb 2016
- HBS Newsroom
Challenge Aims to Speed Drug Trials Process
Re: Bob Kraft (MBA 1965) -
- 01 Mar 2016
- HBS Alumni Bulletin
Off Script
Re: Fred Hassan (MBA 1972); Etienne Locoh-Donou (MBA 2002); Rebecca Leung (MBA 1996); Richard Kaung (MBA 1995); Bunny Ellerin (MBA 1995)
Stories Featuring Kate Bingham
-
- 26 Jan 2021
- HBS Clubs
Clubs See Wealth in FemTech; Health Care Alumni Look at COVID Response
Re: Linda Greub (MBA 1987); Stasia Obremskey (MBA 1987); Alice Zheng (MBA 2014); Rachel Brannan (MBA 1987); Corinne Nevinny (MBA 1987); Heather Myers (MBA 1992); Paul Mango (MBA 1988); Kate Bingham (MBA 1991); Pete Stebbins (MBA 1991); By: Margie Kelley -
- 24 Sep 2020
- HBS Alumni Bulletin
The Race for a Vaccine
Re: Stefan Bancel (MBA 2000); Kate Bingham (MBA 1991); Gary P. Pisano (Harry E. Figgie, Jr. Professor of Business Administration Senior Associate Dean for Faculty Promotions and Tenure); By: April White
